Literature DB >> 1690280

Prostate-specific antigen and prostate gland volume: correlation and clinical application.

R J Babaian1, H A Fritsche, R B Evans.   

Abstract

We studied 103 patients seen in our Prostate Cancer Detection Clinic to determine whether a correlation exists between serum prostate-specific antigen (PSA) values and ultrasound-calculated prostate gland volume. Seventy men (68%) had a PSA value less than or equal to 4 ng/ml (our upper limit of normal). The men were subclassified by prostate gland volume at arbitrary break points. Twenty-five men (24%) had a prostate gland volume less than or equal to 25 cm3; in 96%, the PSA value was less than or equal to 4 mg/ml. Further analysis revealed that the percentage of men with a normal serum PSA value decreased as the prostate gland volume increased; 65.6% of the group with a gland volume between 25 and 50 cm3 (40 of 61) and 35.5% of the group whose prostate volume exceeded 50 cm3 (6 of 17) had PSA values less than or equal to 4 ng/ml. Four men had PSA values greater than 20 ng/ml; all had prostate cancer. Cancer was diagnosed in four additional patients, three with PSA values between 5 and 10 ng/ml and one with a PSA value less than 4 ng/ml. There appears to be a direct relationship between prostate gland volume and PSA value, as well as a cancer value threshold. The clinical implications of these findings are discussed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1690280     DOI: 10.1002/jcla.1860040212

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  9 in total

1.  Twenty Years of PSA: From Prostate Antigen to Tumor Marker.

Authors:  Gabriela De Angelis; Harry G Rittenhouse; Stephen D Mikolajczyk; L Blair Shamel; Axel Semjonow
Journal:  Rev Urol       Date:  2007

Review 2.  Prostate kallikrein markers in diagnosis, risk stratification and prognosis.

Authors:  David Ulmert; M Frank O'Brien; Anders S Bjartell; Hans Lilja
Journal:  Nat Rev Urol       Date:  2009-07       Impact factor: 14.432

Review 3.  [Prostate biopsy. Update for indication, procedure, and future developments].

Authors:  S Machtens; A Roosen; C G Stief; M C Truß
Journal:  Urologe A       Date:  2014-07       Impact factor: 0.639

4.  Advantages of replacing the total PSA assay with the assay for PSA-alpha 1-antichymotrypsin complex for the screening and management of prostate cancer.

Authors:  J T Wu; G H Liu
Journal:  J Clin Lab Anal       Date:  1998       Impact factor: 2.352

5.  Population standards of prostate specific antigen values in men over 40: community based study in Turkey.

Authors:  Talha Müezzinoğlu; Murat Lekili; Erhan Eser; Bekir S Uyanik; Coşkun Büyüksu
Journal:  Int Urol Nephrol       Date:  2005       Impact factor: 2.370

6.  Beyond prostate-specific antigen: new serologic biomarkers for improved diagnosis and management of prostate cancer.

Authors:  Shahrokh F Shariat; Eduardo I Canto; Michael W Kattan; Kevin M Slawin
Journal:  Rev Urol       Date:  2004

7.  BPSA: A Novel Serum Marker for Benign Prostatic Hyperplasia.

Authors:  Kevin M Slawin; Shahrokh Shariat; Eduardo Canto
Journal:  Rev Urol       Date:  2005

8.  An algorithm for prostate cancer detection in a patient population using prostate-specific antigen and prostate-specific antigen density.

Authors:  M C Benson; D J McMahon; W H Cooner; C A Olsson
Journal:  World J Urol       Date:  1993       Impact factor: 4.226

9.  Why I cannot find the prostate? Behind the subjectivity of rectal exam.

Authors:  Dmitry Koulikov; Ariel Mamber; Alon Fridmans; Wael Abu Arafeh; Ofer Z Shenfeld
Journal:  ISRN Urol       Date:  2012-02-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.